NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Innate Immunity

• Publication date

  2011-05-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000328505PMID 21576932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased expression of DNAM‐1 on NK cells from acute myeloid leukemia patients

  2012cited by this paper
• The Bidirectional Crosstalk between Human Dendritic Cells and Natural Killer Cells

  2011cited by this paper
• Role of Natural Killer Cells in Hematopoietic Stem Cell Transplantation: Myth or Reality?

  2011cited by this paper
• Natural Killer Cell Responses to Viral Infection

  2011cited by this paper
• Interleukin 10 decreases MICA expression on melanoma cell surface

  2011cited by this paper
• Effect of NKG2D ligand expression on host immune responses

  2010cited by this paper
• The Determination of Melanoma Stage at Diagnosis

  2010cited by this paper
• The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions

  2010cited by this paper
• Immunity unleashed in melanoma.

  2010cited by this paper
• Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome

  2010cited by this paper
• Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy.

  2010cited by this paper
• New views on natural killer cell-based immunotherapy for melanoma treatment.

  2010cited by this paper
• Interferon‐γ down‐regulates NKG2D ligand expression and impairs the NKG2D‐mediated cytolysis of MHC class I‐deficient melanoma by natural killer cells

  2009cited by this paper
• Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells

  2009cited by this paper
• The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

  2009cited by this paper
• DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases

  2009cited by this paper
• Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells1

  2009cited by this paper
• Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.

  2009cited by this paper
• Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

  2009cited by this paper
• The B 7 family member B 7-H 6 is a tumor cell ligand for the activating natural killer cell receptor NKp 30 in humans

  2009cited by this paper
• Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B

  2009cited by this paper
• Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells

  2009cited by this paper
• Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells.

  2009cited by this paper
• HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank

  2009cited by this paper
• Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

  2009cited by this paper
• NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

  2009cited by this paper
• Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells

  2009cited by this paper
• Accelerated tumor growth in mice deficient in DNAM-1 receptor

  2008cited by this paper
• NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy

  2008cited by this paper
• Negative signaling by inhibitory receptors: the NK cell paradigm

  2008cited by this paper
• DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

  2008cited by this paper
• Natural killer cell–directed therapies: moving from unexpected results to successful strategies

  2008cited by this paper
• Expression of ligands to NKp46 in benign and malignant melanocytes.

  2008cited by this paper
• Line of attack: NK cell specificity and integration of signals.

  2008cited by this paper
• NK cells and cancer immunosurveillance

  2008cited by this paper
• The NKG2D receptor: immunobiology and clinical implications

  2008cited by this paper
• Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44

  2007cited by this paper
• Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

  2007cited by this paper
• Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients

  2007cited by this paper
• NKG2D-Mediated Antitumor Activity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated from Melanoma Patients

  2007cited by this paper
• Tumor-Primed Human Natural Killer Cells Lyse NK-Resistant Tumor Targets: Evidence of a Two-Stage Process in Resting NK Cell Activation1

  2007cited by this paper
• NKG 2 D-Mediated AntitumorActivity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated fromMelanoma Patients

  2007cited by this paper
• Activation, coactivation, and costimulation of resting human natural killer cells

  2006cited by this paper
• Decreased frequency and proliferative response of invariant Vα24Vβ11 natural killer T (iNKT) cells in healthy elderly

  2006cited by this paper
• Tumor and viral recognition by natural killer cells receptors.

  2006cited by this paper
• Human natural killer cell development and biology.

  2006cited by this paper
• Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands

  2006cited by this paper
• Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.

  2006cited by this paper
• NK cell activating receptors and tumor recognition in humans.

  2006cited by this paper
• PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.

  2005cited by this paper
• Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).

  2004cited by this paper
• Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma

  2004cited by this paper
• Identification of PVR ( CD 155 ) and Nectin-2 ( CD 112 ) as Cell Surface Ligands for the Human DNAM-1 ( CD 226 ) Activating Molecule

  2003cited by this paper
• Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

  2003cited by this paper
• Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.

  2002cited by this paper
• Expression of stress-induced MHC class I related chain molecules on human melanoma.

  2002cited by this paper
• Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.

  2002cited by this paper
• Human NK-cell receptors.

  2000cited by this paper
• Identification and Molecular Characterization of NKp 30 , a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

  1999cited by this paper
• NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells

  1999cited by this paper
• Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

  1999cited by this paper
• Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity

  1998cited by this paper
• The susceptibility to natural killer cell‐mediated lysis of HLA class I‐positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles

  1998cited by this paper
• In search of the 'missing self': MHC molecules and NK cell recognition.

  1990cited by this paper

• Trying to Kill a Killer; Impressive Killing of Patient Derived Glioblastoma Cultures Using NK-92 Natural Killer Cells Reveals Both Sensitive and Highly Resistant Glioblastoma Cells

  2025cites this paper
• Melanoma of unknown primary: a comprehensive review of immune-mediated pathogenesis and therapies

  2025cites this paper
• Biomimetic nanosystems based on cell membranes (BNCMs) for cancer immunotherapy

  2024cites this paper
• Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

  2024cites this paper
• NKG2C+CD57+ natural killer with senescent features cells are induced in cutaneous leishmaniasis and accumulate in patients with lesional healing impairment.

  2024cites this paper
• Higher CD16-NKp46bright uterine endometrial natural killer cells may predict pregnancy success in women experiencing recurrent reproductive failure.

  2024cites this paper
• IFNγ mediates the resistance of tumor cells to distinct NK cell subsets

  2024cites this paper
• Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function

  2023cites this paper
• The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies

  2023cites this paper
• NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats

  2023cites this paper
• Multifunctional NK Cell–Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine Release

  2022cites this paper
• Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment

  2022cites this paper
• Single-cell mechanistic studies of radiation-mediated bystander effects

  2022cites this paper
• Natural killer cell-derived extracellular vesicle significantly enhanced adoptive T cell therapy against solid tumors via versatilely immunomodulatory coordination

  2021cites this paper
• NK cells associate with ALS in a sex- and age-dependent manner

  2021cites this paper
• Memory-like Differentiation Enhances NK Cell Responses to Melanoma

  2021cites this paper
• Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy

  2021cites this paper
• Recent Advances of Cell Membrane‐Coated Nanomaterials for Biomedical Applications

  2020cites this paper
• Aging of Natural Killer Cells in Acute Myeloid Leukemia

  2020cites this paper
• Current progress in NK cell biology and NK cell-based cancer immunotherapy

  2020cites this paper
• K Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations.

  2020cites this paper
• NK Cell-mediated Neuroblastoma Cell Lysis is Enhanced by IgG From Patients With Pediatric Opsoclonus-Myoclonus Syndrome.

  2020cites this paper
• Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy

  2019cites this paper
• Chronic Ly49H Receptor Engagement in vivo Decreases NK Cell Response to Stimulation Through ITAM-Dependent and Independent Pathways Both in vitro and in vivo

  2019cites this paper
• Artificial Natural Killer Cells for Specific Tumor Inhibition and Renegade Macrophage Re‐Education

  2019cites this paper
• Molecular Pathway and Fluorescence In Situ Hybridization Testing of ERBB2 (HER2) Gene Amplification in Invasive Ductal Carcinoma of Breast

  2019cites this paper
• The rise of human stem cell-derived natural killer cells for cancer immunotherapy

  2019cites this paper
• Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation

  2019cites this paper
• NKG2D Polymorphism in Melanoma Patients from Southeastern Spain

  2019cites this paper
• Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth.

  2018cites this paper
• Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti‐tumor effects

  2018cites this paper
• Immunosenescence: limitations of natural killer cell-based cancer immunotherapy

  2017cites this paper
• Attenuated in vitro effects of IFN‐&agr;, IL‐2 and IL‐12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients

  2017cites this paper
• Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model

  2017cites this paper
• Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy

  2017cites this paper
• Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility

  2016cites this paper
• NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution

  2016cites this paper
• HLA y expresión de receptores NK en pacientes con melanoma

  2016cites this paper
• Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy

  2016cites this paper
• Critical roles of co‐activation receptor DNAX accessory molecule‐1 in natural killer cell immunity

  2015cites this paper
• DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies

  2015cites this paper
• MHC Class I Chain-Related Gene A Diversity in Patients with Cutaneous Malignant Melanoma from Southeastern Spain

  2015cites this paper
• Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells

  2015cites this paper
• Natural killer cell receptors: alterations and therapeutic targeting in malignancies

  2015cites this paper
• Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma.

  2015cites this paper
• Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients

  2014cites this paper
• UPR decreases CD226 ligand CD155 expression and sensitivity to NK cell‐mediated cytotoxicity in hepatoma cells

  2014cites this paper
• Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancer.

  2014cites this paper
• Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer

  2014cites this paper
• Natural Killer Cell Immunosenescence and Cancer in the Elderly

  2014cites this paper
• Brief Exercise Increases Peripheral Blood NK Cell Counts without Immediate Functional Changes, but Impairs their Responses to ex vivo Stimulation

  2013cites this paper
• Human Herpesviridae Methods of Natural Killer Cell Evasion

  2012cites this paper
• Virus Immune Evasion: New Mechanism and Implications in Disease Outcome

  2012cites this paper
• Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.

  2012cites this paper
• NK Cells in Healthy Aging and Age-Associated Diseases

  2012cites this paper
• Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands

  2011cites this paper
• Natural Killer Cells: Biology, Physiology and Medicine – Part 2

  2011cites this paper